Wednesday, April 8, 2009

Mylan Announces Clarinex Settlement Agreement

Mylan Inc. today announced the settlement of all patent litigation relating to Desloratadine Tablets, 5 mg, the generic version of Schering- Plough's Clarinex(R) allergy medication. This litigation has been pending in the U.S. District Court of New Jersey since September 2006.

The details can be read here.

No comments: